Table 2.
NK sub-populations | Combo (n = 16 U) |
PB (n = 13 U) |
p Value | ||
---|---|---|---|---|---|
Mean (%) | SD | Mean% | SD | ||
CD16− | 60.94 | 16.58 | 21.38 | 14.00 | *** |
CD16+ | 39.05 | 16.58 | 78.63 | 14.01 | *** |
KIR3DL1+ | 12.31 | 8.11 | 7.07 | 8.28 | NS |
KIR2DL2/L3+ | 21.89 | 8.65 | 9.46 | 11.31 | ** |
NKG2D+ | 42.11 | 17.79 | 29.88 | 22.64 | NS |
NKp46+ | 6.98 | 4.33 | 18.86 | 13.97 | * |
CD226+ | 15.97 | 6.66 | 26.75 | 23.31 | NS |
NKp44+ | 9.48 | 5.27 | 4.89 | 6.40 | NS |
NKp30+ | 39.08 | 19.06 | 18.99 | 20.86 | ** |
2B4+ | 11.07 | 5.90 | 4.46 | 6.45 | * |
CD94+ | 71.31 | 13.94 | 26.17 | 30.49 | *** |
NS, not significant; *p < 0.05; **p < 0.01; ***p < 0.001.